FAS agreed on the price of the nasal spray for influenza “Grippferon” – Kommersant
[ad_1]
The Federal Antimonopoly Service (FAS) of Russia agreed on the maximum selling price for the Grippferon nasal cough spray, which allowed it to resume its sales in the country, which were suspended in August 2022.
As reported department, the maximum price for “Grippferon” will be 230.86 rubles. excluding VAT and trade markups. The FAS clarified that the spray is included in the list of vital and essential medicines in the Russian Federation.
Previously, the Antimonopoly Service analyzed the declared prices for the drug twice, but the manufacturer was refused to set the maximum price for it both times. The reason was the manufacturer’s desire to set too high a price for the nasal spray.
[ad_2]
Source link
